Vanda Pharmaceuticals
VNDA
VNDA
179 hedge funds and large institutions have $867M invested in Vanda Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 60 increasing their positions, 72 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0.3% less ownership
Funds ownership: 99.43% → 99.13% (-0.3%)
17% less repeat investments, than reductions
Existing positions increased: 60 | Existing positions reduced: 72
79% less call options, than puts
Call options by funds: $738K | Put options by funds: $3.55M
Holders
179
Holding in Top 10
1
Calls
$738K
Puts
$3.55M
Top Buyers
| 1 | +$8.69M | |
| 2 | +$5.12M | |
| 3 | +$5.04M | |
| 4 |
BlackRock
New York
|
+$5.03M |
| 5 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
+$4.24M |
Top Sellers
| 1 | -$11.8M | |
| 2 | -$7.34M | |
| 3 | -$5.95M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$5.45M |
| 5 |
Goldman Sachs
New York
|
-$5.05M |